Stock listing
SBFM Stock Price, News, Filings & Events — Sunshine Biopharma Inc.
Selected listing: SBFM · BOATS · USD · US
This page tracks Sunshine Biopharma Inc.'s SBFM:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SBFM:BOATS. SBFM:BOATS is the stock-level entry point for investors researching Sunshine Biopharma Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Sunshine Biopharma Inc. (SBFM) is a public company based in the United States, with a market capitalization of approximately $3.95 million. The company focuses on developing innovative pharmaceutical solutions. Sunshine Biopharma is dedicated to addressing unmet medical needs through its research and development efforts.
- Ticker
- SBFM:BOATS
- Asset type
- Stock
- Market cap
- $4.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
Sunshine Biopharma Inc. SBFM:BOATS stock context
This page tracks Sunshine Biopharma Inc.'s SBFM:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SBFM:BOATS. SBFM:BOATS is the stock-level entry point for investors researching Sunshine Biopharma Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Sunshine Biopharma Inc. (SBFM) is a public company based in the United States, with a market capitalization of approximately $3.95 million. The company focuses on developing innovative pharmaceutical solutions. Sunshine Biopharma is dedicated to addressing unmet medical needs through its research and development efforts.
Latest news from Sunshine Biopharma Inc.
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions
August 31, 2026
Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer
August 26, 2026
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
August 19, 2026
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market
August 7, 2026
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
August 4, 2026
Research Sunshine Biopharma Inc.
Sunshine Biopharma Inc. investor report
Review AI stock analysis and investor report context for SBFM:BOATS.
Sunshine Biopharma Inc. company profile
View the public company page for Sunshine Biopharma Inc. on 6ix.
Sunshine Biopharma Inc. news
Read company news and market updates connected to Sunshine Biopharma Inc..
Sunshine Biopharma Inc. investor events
Find investor webinars, events, and replay context for Sunshine Biopharma Inc..